Back

Benefits and risks of antithrombotic therapy in diabetes.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD) Lipids Open Access ESC Congress 2019

About the speaker

Photo
Professor Bianca Rocca

LUM University, Casamassima (Italy)

4 More presentations in this session

Presentation thumbnail
What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
Professor F. Cosentino (Stockholm, SE)
Slides Video
Presentation thumbnail
Management of dyslipidaemias.
Doctor M. Lettino (Monza, IT)
Slides Video
Presentation thumbnail
New evidence from cardiovascular outcome trials.
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Glucose-lowering drugs and heart failure.
Professor P. Seferovic (Belgrade, RS)
Slides Video

Access the full session

Session thumbnail
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Lipoprotein(a): a modifiable risk factor of atherosclerotic cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources